We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

89 hedge funds and large institutions have $7.24M invested in Ampio Pharmaceuticals Inc. in 2018 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 21 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,005% more call options, than puts

Call options by funds: $221K | Put options by funds: $20K

80% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 10

31% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 16

10% more funds holding

Funds holding: 81 → 89 (+8)

18% less capital invested

Capital invested by funds: $8.82M → $7.24M (-$1.58M)

Holders
89
Holders Change
+8
Holders Change %
+9.88%
% of All Funds
1.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
21
Reduced
16
Closed
10
Calls
$221K
Puts
$20K
Net Calls
+$201K
Net Calls Change
-$14K

Top Buyers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
+$341K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$212K
3
MA
Montag & Associates
Georgia
+$94.7K
4
SFS
Strategic Financial Services
New York
+$71.7K
5
NFG
Noven Financial Group
Colorado
+$63.4K

Top Sellers

Rank Fund Capital Flow
1
Russell Investments Group
Russell Investments Group
United Kingdom
-$220K
2
Deutsche Bank
Deutsche Bank
Germany
-$205K
3
CCMW
Cypress Capital Management (Wyoming)
Wyoming
-$53.6K
4
BCM
Bridgeway Capital Management
Texas
-$51K
5
BCM
BlueCrest Capital Management
Jersey
-$50K
Name Holding Trade Value Shares
Change 		Change in
Stake
PAG
51
Private Advisor Group
New Jersey
$8K -$614 -4 -6%
California Public Employees Retirement System
52
California Public Employees Retirement System
California
$8K – – –
OWP
53
Obermeyer Wealth Partners
Colorado
$8K – – –
TFS
54
TrustCore Financial Services
Tennessee
$7K -$2K -13 -19%
JWM
55
Janiczek Wealth Management
Colorado
$7K – – –
CS
56
Credit Suisse
Switzerland
$7K +$8.44K +55 New
RJA
57
Raymond James & Associates
Florida
$6K -$31.9K -208 -80%
AB
58
Amalgamated Bank
New York
$6K +$7.21K +47 New
BCM
59
Brookstone Capital Management
Illinois
$5K – – –
Legal & General Group
60
Legal & General Group
United Kingdom
$5K – – –
PNC Financial Services Group
61
PNC Financial Services Group
Pennsylvania
$5K – – –
GWM
62
Geneos Wealth Management
Colorado
$5K +$921 +6 +14%
BMO
63
Beck Mack & Oliver
New York
$5K +$6.45K +42 New
TRCT
64
Tower Research Capital (TRC)
New York
$5K +$6.75K +44 New
RE
65
RBC Europe
United Kingdom
$4.47K – – –
ProShare Advisors
66
ProShare Advisors
Maryland
$4K -$921 -6 -15%
CAL
67
Capital Analysts LLC
Pennsylvania
$4K – – –
OC
68
Oppenheimer & Co
New York
$4K – – –
AIP
69
Ameritas Investment Partners
Nebraska
$3K – – –
WA
70
WealthTrust Axiom
Pennsylvania
$3K – – –
Northwestern Mutual Wealth Management
71
Northwestern Mutual Wealth Management
Wisconsin
$3K +$3.99K +26 New
LTFS
72
Ladenburg Thalmann Financial Services
Florida
$2K – – –
MAM
73
Meeder Asset Management
Ohio
$2K +$2.15K +14 +700%
LPC
74
Loeb Partners Corp
New York
$2K +$2.61K +17 New
APA
75
American Portfolios Advisors
New York
$1.18K – – –
1 2
3
4

AMPE Hedge Fund Activity: Q4 2018 in Review

89 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q4 2018, worth a combined $7.24M — down 18% from $8.82M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new AMPE positions and 10 closed out — a net gain of 8 holders — while 21 added to existing stakes and 16 trimmed.

The largest buyer was GSA Capital Partners, opening a new position worth an estimated $341K. The largest seller was Russell Investments Group, exiting entirely with an estimated $220K sold.

  • 89 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q4 2018, up from 81 in Q3 2018.
  • Funds reported $7.24M of Ampio Pharmaceuticals Inc. stock for Q4 2018, down 18% quarter-over-quarter.
  • 18 funds opened new Ampio Pharmaceuticals Inc. positions in Q4 2018 and 10 closed out, a net change of +8 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q4 2018 was GSA Capital Partners, an estimated $341K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q4 2018 was Russell Investments Group, an estimated $220K sold.

Based on aggregated 13F filings for Q4 2018.